Waypoint Capital Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $243K | Sell |
480
-12
| -2% | -$6.06K | 0.05% | 118 |
|
2024
Q2 | $240K | Buy |
492
+12
| +3% | +$5.85K | 0.06% | 113 |
|
2024
Q1 | $259K | Buy |
480
+80
| +20% | +$43.2K | 0.07% | 105 |
|
2023
Q4 | $222K | Buy |
+400
| New | +$222K | 0.06% | 111 |
|
2023
Q3 | – | Sell |
-404
| Closed | -$203K | – | 122 |
|
2023
Q2 | $203K | Buy |
404
+4
| +1% | +$2.01K | 0.06% | 129 |
|
2023
Q1 | $200K | Buy |
+400
| New | +$200K | 0.07% | 130 |
|
2022
Q2 | – | Sell |
-502
| Closed | -$275K | – | 123 |
|
2022
Q1 | $275K | Buy |
502
+1
| +0.2% | +$548 | 0.16% | 98 |
|
2021
Q4 | $330K | Buy |
+501
| New | +$330K | 0.23% | 69 |
|